Work

Screening for potent and selective anticlostridial leads among FDA-approved drugs

Year: 2020

Type: article

Source: The Journal of Antibiotics

DOI: 10.1038/s41429-020-0288-3

Authors: Ahmed AbdelKhalek, Haroon Mohammad, Abdelrahman S. Mayhoub, Mohamed N. Seleem

Institutions: Purdue University West Lafayette, Al-Azhar University, Zewail City of Science and Technology

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases

Awards: Repurposing auranofin and ebselen for treatment of multidrug resistant pathogens, G5938605461

OpenAlex ID: W3009225031

FWCI: 0.332

Cites: 51

Cited by: 18

Related to: 10